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Microglial-derived miRNA let-7 and HMGB1
contribute to ethanol-induced neurotoxicity
via TLR7
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Abstract
Background: Toll-like receptor (TLR) signaling is emerging as an important component of neurodegeneration. TLR7
senses viral RNA and certain endogenous miRNAs to initiate innate immune responses leading to neurodegeneration.
Alcoholism is associated with hippocampal degeneration, with preclinical studies linking ethanol-induced
neurodegeneration with central innate immune induction and TLR activation. The endogenous miRNA let-7b
binds TLR7 to cause neurodegeneration.
Methods: TLR7 and other immune markers were assessed in postmortem human hippocampal tissue that was
obtained from the New South Wales Tissue Bank. Rat hippocampal-entorhinal cortex (HEC) slice culture was used
to assess specific effects of ethanol on TLR7, let-7b, and microvesicles.
Results: We report here that hippocampal tissue from postmortem human alcoholic brains shows increased
expression of TLR7 and increased microglial activation. Using HEC slice culture, we found that ethanol induces
TLR7 and let-7b expression. Ethanol caused TLR7-associated neuroimmune gene induction and initiated the
release let-7b in microvesicles (MVs), enhancing TLR7-mediated neurotoxicity. Further, ethanol increased let-7b
binding to the danger signaling molecule high mobility group box-1 (HMGB1) in MVs, while reducing let-7
binding to classical chaperone protein argonaute (Ago2). Flow cytometric analysis of MVs from HEC media and
analysis of MVs from brain cell culture lines found that microglia were the primary source of let-7b and HMGB1-
containing MVs.
Conclusions: Our results identify that ethanol induces neuroimmune pathology involving the release of let-7b/
HMGB1 complexes in microglia-derived microvesicles. This contributes to hippocampal neurodegeneration and
may play a role in the pathology of alcoholism.
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Background
The role of Toll-like receptors (TLRs) in innate immunity
has recently been illuminated. TLRs recognize damage-
associated molecular pattern molecules (DAMPs) to initi-
ate innate immune signaling cascades. In the CNS,
however, TLRs function not only as agents of immunity,
but regulate neuronal morphology, pain, and
neurodegeneration through recognition of endogenous ag-
onists [1–3]. TLR7 is an endosomal TLR that recognizes
endogenous micro-RNAs (miRs), single-stranded RNAs
(ss), and short interfering (si) RNAs [4]. TLR7 signaling
can lead to activation of transcription factors IRF7 or
NFκB and cause either neuroimmune responses or neuro-
degeneration [4–7]. The endogenous TLR7 agonist miR
let-7 has been found to cause neurodegeneration [6]. let-
7b in particular has a GU-rich region that is readily recog-
nized by TLR7. Studies utilizing miRNA profiling find in-
creased expression of several let-7 isoforms in human and
rodent brain after chronic alcohol [8, 9].
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Both neuroimmune activation and neurodegeneration
are inseparable in many CNS disorders including alco-
holism [10], Parkinson’s [11, 12], and Alzheimer’s disease
[13, 14]. Alcoholism is associated with progressive neu-
rodegeneration throughout the brain including the
hippocampus and cortex [15–17]. Neuroimmune activa-
tion precedes and exacerbates neurodegeneration [18–
20]. Ethanol activates the neuroimmune system through
TLR activation and the release of endogenous DAMPs,
such as the TLR4 agonist high mobility group box-1
(HMGB1). Studies of postmortem human alcoholic
brains, in vivo rodent studies, and in vitro hippocampal-
entorhinal brain slice culture (HEC) show that ethanol
increases the cortical expression of TLRs 2-4, HMGB1
[10, 21, 22]. Peripherally, ethanol causes the release of
microvesicles (MVs) into the circulation that contain
pro-inflammatory miRNAs [23, 24]. Since TLR7 activa-
tion causes both innate immune activation and neurode-
generation, we hypothesized that ethanol would activate
TLR7 signaling leading to innate immune gene induc-
tion. We further hypothesized that ethanol would cause
the release of the endogenous TLR7 agonist miR let-7b
in MVs. HMGB1 is a nucleic acid binding protein that is
released from neurons by ethanol [21, 22]. HMGB1 is
required for immune responses to TLR7 agonists [25]
and acts as a chaperone for DNA or cytokines potentiat-
ing their function through their native receptors [26–
28]. HMGB1 is released in MVs and ethanol increases
expression and active secretion of HMGB1 from the
brain [22, 29]. Thus, we hypothesized that HMGB1
would bind miR let-7b in MVs to help facilitate its activ-
ity as an endogenous agonist of TLR7.
We report here in postmortem human alcoholic hippo-
campal brain tissue that TLR7, HMGB1, and the microglia
activation marker CD11b are increased. Interestingly,
TLR7 expression in human hippocampus correlated with
lifetime alcohol intake, suggesting a role in the pathology
of the disease. In rat HEC brain slice culture, we found
that ethanol increases TLR7, HMGB1, IL-1β, TNFα, and
let-7b consistent with findings in human alcoholics. Con-
comitant with the increase in TLR7, ethanol also increases
the release of let-7b and HMGB1 in MVs and potentiates
let-7b induced neurodegeneration via TLR7 activation.
Using RNA immuno-purification followed by RT-PCR
(RIP assay), we found that HMGB1 forms heterodimeric
complexes with let-7b in MVs in response to ethanol.
Using flow cytometry for MVs from HEC slice culture and
analysis of SH-SY5Y neuronal and BV2 microglia cell
lines, we found that the majority of microvesicular
HMGB1 and let-7b are derived from microglia. Thus, we
report here the identification of a novel inter-cellular com-
munication mechanism in the pathology of alcohol abuse,
whereby ethanol causes the release of HMGB1-let-7 com-
plexes in MV from microglia.
Methods
Reagents
The following reagents were purchased from Sigma-
Aldrich (St Louis, USA): imiquimod (I5159) and glycyr-
rhizin (G2137). HMGB1 ELISA kit was purchased from
IBL International (Hamburg, Germany); primary anti-
bodies from Novus Biologicals: Na+/K+ ATPase α3
(NB300-540APC), GFAP (NBP2-34401 V2), CD11b
(NBP2-34678PE), and HMGB1 (NB100-2322AF488);
and primary antibodies from Abcam: CD11b for western
blot (ab75476), argonaute 2 (ab32381).
Hippocampal-entorhinal cortex slice culture
All protocols followed in this study were approved by
the Institutional Animal Care Use Committee at UNC
and were in accordance with National Institute of Health
regulation for the care and use of animal in research.
Organotypic brain slice cultures are prepared as de-
scribed previously [22]. Briefly, the hippocampal entorhi-
nal region is dissected and sliced transversely from post-
natal day 7 rat pups. Slices are 375 μm thick. HEC slices
were placed onto tissue insert membrane (10 slices/in-
sert) and cultured with medium containing 75% MEM
with 25 mM HEPES and Hank’s salts, 25% horse serum
(HS), 5.5 g/L glucose, 2 mM L-glutamine in a humidified
5% CO2 incubator at 36.5 °C for 7 days in vitro (DIV),
followed by 4 DIV in medium containing 12.5% HS and
then 3 DIV in serum-free medium supplemented with
N2. The cultures after 14 DIV were used for experi-
ments and drug treatments with serum-free N2-
supplemented medium. For ethanol exposures, slices
were exposed to ethanol (25–100 mM) for 48 h. For let-
7b mimic exposure studies, slices were treated with
DOTAP, DOTAP plus let-7b mimic, or let-7b mimic plus
ethanol for 48 h. For TLR7 agonist enhancement studies,
slices were treated with either 500 ng/mL of imiquimod
(IMQ) or vehicle for 48 h, followed by addition of either
ethanol (100 mM) or vehicle for 96 h.
Immunofluorescent staining and analysis
HEC slice cultures were removed at the end of the ex-
periment and fixed with 4% paraformaldehyde with 5%
sucrose in 0.01 M PBS for 24 h at 4 °C. All primary anti-
bodies were incubated for 48 h at 4 °C. Either Alexa
Fluor 594 or Alexa Fluor 488 secondary antibodies
(1:2000; Molecular Probes, Eugene, OR) were used for
immunofluorescent staining and incubated for 1 h at
room temperature. The slices were coverslipped with
anti-fade mounting medium (pro-long; Molecular
Probes). Images were obtained using a LeicaSP2 AOBS
Upright Laser Scanning Confocal in Michael Hooker
Microscopy Facility (University of North Carolina,
Chapel Hill, NC). Fluorescent pixel density analysis was
performed using ImageJTM software.
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Neuronal and microglial cell line experiments
SH-SY5Y and BV2 cells were allowed to grow in culture
as described previously in standard cell culture condi-
tions [30, 31]. For BV2 microglia and SH-SY5Y neuronal
experiments, 3 × 105 cells/well were plated on 6-well
CorningTM cell culture plates. Cells were allowed to ad-
here overnight, and the next morning, they were treated
with ethanol (100 mM) for 24 h.
Postmortem human alcoholic analyses
Frozen postmortem human hippocampal tissue was ob-
tained from the New South Wales Brain Tissue Bank in
Sidney Australia as described previously [21]. Approxi-
mately 100 mg of tissue was provided for each subject.
Given the small fragments of tissue, morphological as-
sessment was not possible. Individuals with comorbid
liver cirrhosis or nutritional deficiencies were excluded.
The leading common cause of death was cardiovascular
disease for both groups (16/18). Postmortem intervals
were also documented and did not correlate with mRNA
measurements. Psychiatric and alcohol use disorder
diagnoses were confirmed using the Diagnostic Instru-
ment for Brain Studies, which is in compliance with the
Diagnostic Statistical Manual of Mental Disorders [32].
Details for each subject are provided in Table 2.
Isolation of mRNA, miRNA, and quantification via RT-PCR
Isolation of mRNA was performed as previously [22].
Briefly, total RNA or miRNA were isolated using RNeasy
Mini Kit or the miRNeasy Mini Kit respectively (QIA-
GEN Inc., CA). RNA quantification was performed using
a nanodrop 2000TM spectrophotometer. RIN scores were
obtained after RNA isolation using the Agilent Bioanaly-
zer 2100 (Agilent Technologies, Santa Clara, CA) to de-
termine RNA integrity as described previously [33]. For
mRNA reverse transcription, 2 μg of RNA was used to
synthesize cDNA using random primers (Invitrogen)
and reverse transcriptase Moloney murine leukemia
virus (Invitrogen). The primer sequences used for re-
verse transcriptase of mRNA targets are included in
Table 1. Genes of interest were normalized to house-
keeping genes β actin for mRNA analyses and snRU6 for
miRNA analyses. Importantly, ethanol did not cause sig-
nificant reductions in β actin, indicating its adequacy as
a housekeeping gene. For miRNA, TaqManTM Advanced
miRNA cDNA Synthesis Kit was used for reverse tran-
scriptase. The known sequences for the measured miR-
NAs were mature miR let-7b (UGAGGUAGUAGGUUG
UGUGGUU), miR-155 (CUCCUACCUGUUAGCAUUA
AC), and miR 181c AACAUUCAACCUGUCGG
UGAGU.
Microvesicle isolation
MVs are isolated by sequential centrifugation as de-
scribed previously [29]. Briefly, media was centrifuged at
2000g for 20 min to remove cells. Supernatant was then
centrifuged at 10,000g for 30 min to remove cellular
debris. Remaining supernatant was then centrifuged at
21,000g for 1 h. The MV-containing pellet was washed
in PBS and centrifuged again at 21,000g. The MV pellet
was suspended in the appropriate buffer for analysis.
This preparation results in MVs ranging between
100 nm and 1 μm in diameter.
ELISA measurements of HMGB1
Media HMGB1 levels were determined from undiluted
media by ELISA (IBL, Germany) according to the manu-
facturer’s instruction. Tissue levels of HMGB1 from hu-
man hippocampus were measured by ELISA. Samples
were first treated with perchloric acid (BioVision catalog
#K808) to separate HMGB1 from its binding partners as
previously described [34]. Purified supernatant was then
assessed by ELISA at a dilution of 1:25.
Flow cytometric analysis of microvesicle cellular origin
Composition and cell origin of MVs was done as de-
scribed [35, 36]. Briefly, MVs were permeabilized with
Fix/Perm buffer (Biolegend), incubated with Fc blocking
buffer (Biolegend), and labeled using antibodies to
HMGB1, GFAP (astrocytes), Na+/K+ ATPase α3 (neu-
rons), and CD11b (microglia). Samples are incubated
with fluorescent secondary antibodies when appropriate.
The Stratedigm S1000Ex was used to assess the stained
MVs at the UNC Flow Cytometry Core Facility. Size
gates to identify MVs (0.1–1.0 μm) were set using Mega-
MixTM (BioCytex) size gating beads (Additional file 1:
Figure S1A). Single color controls for each primary anti-
body, compared to unstained media, were used to de-
velop the compensation matrix and distinguish
background staining from specific staining using FloJoTM
software version 10.0 (Additional file 1: Figure S1B). Ap-
proximately 5% of the MVs stained positive for lactad-
herin, which binds phosphotidyl-serine (PS). Of the PS+
MVs, ethanol increased HMGB1 in a dose-dependent
fashion up to 123% of controls at 75 mM (not shown).
RIP assays
Media MVs were isolated by centrifugation as described
above. The MV pellet was lysed in 0.1% Triton X-100
Table 1 Primers used for mRNA and miRNA quantification by
RT-PCR
Target Forward (5′ to 3′) Reverse (5′ to 3′)
IL-1β GAAACAGCAATGGTCGGGAC AAGACACGGGTTCCATGGTG
TNFα AGCCCTGGTATGAGCCCATGTA CCGGACTCCGTGATGTCTAAG
TLR7 AGCTCTGTTCTCCTCCACCA CATGGGTGTTTGTGCTATCG
β-actin CTACAATGAGCTGCGTGTGGC CAGGTCCAGACGCAGGATGGC
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containing buffer. MV HMGB1 was immunopurified
using Dynabeads® M-270 Epoxy (ThermoFisher 14321D)
according to the manufacturer’s instructions as de-
scribed [37]. Briefly, Dynabeads were coupled overnight
to either an anti-HMGB1 antibody (Abcam ab18256) or
anti-Ago2 (ab32381). MV protein was incubated with
anti-HMGB1 coupled Dynabeads overnight at 4 °C.
HMGB1 was then eluted from the Dynabeads and incu-
bated in TrizolTM buffer. Micro-RNA isolation was per-
formed as above, with the same amount of total mRNA
assessed for RT-PCR per sample. let-7b, miR-155, and
miR181c were assessed as described above.
Western blot
Human brain tissue was homogenized and sonicated in
Tris lysis buffer containing 7.4% EDTA, 3.8% EGTA, and
1% Triton X-100. Lystates were centrifuged at 21,000g to
remove the nuclear fraction. Samples were diluted in
equal amounts of RIPA and DTT containing reducing
buffer (Pierce TM catalog number 39000) to a final
amount of either 30 or 40 μg protein per well. Samples
were run on 4–15% Ready Gel Tris-HCL gel (BioRad)
and transferred onto PVDF membranes (BioRad).
Membranes were incubated overnight at 4 °C with pri-
mary antibody. Secondary incubation was performed the
following day and membranes visualized and bands
quantified using the LiCor Odyssey imaging systemTM.
Values for proteins of interest were normalized to beta
actin expression for each subject.
Assessment of neuronal cell death
The uptake of the fluorescent exclusion dye propidium
iodide (PI) was used for determination of neuronal cell
death. PI is a polar compound that is impermeable to a
cell with an intact cell membrane but penetrates dam-
aged cell membranes. Inside the cells, it binds nuclear
DNA to generate the brightly red fluorescence. This
method has been well characterized as accurately meas-
uring neuronal degeneration in organotypic slice cul-
tures [38]. For each experiment, PI was added into the
culture medium at the beginning of treatment at a con-
centration of 5 μg/ml and PI fluorescence images were
captured at indicated time points. PI fluorescent inten-
sity was measured and analyzed with the AxioVision 3.1
software. Mean fluorescent density was quantified using
ImageJTM software.
Table 2 Demographics of alcoholics and control subjects from New South Wales Brain Tissue Bank
DSM V alcohol classification Age PMI Brain pH RIN Lifetime alcohol (kg) Cause of death Agonal state/mode of death
Control 24 43 6.27 6.2 15 Arrhythmia Rapid
Control 40 27 6.79 7.4 47 Pulmonary embolus Intermediate
Control 44 50 6.6 7.1 28 IHD Rapid
Control 46 29 6.12 4.4 115 MI Intermediate
Control 48 24 6.73 6.9 17 IHD Rapid
Control 50 30 6.37 7.5 0 IHD Rapid
Control 50 40 6.87 8.6 18 Hemopericardium Rapid
Control 53 16 6.84 7.9 102 Cardiomyopathy Rapid
Control 60 28 6.8 8 0 IHD Rapid
Control 62 46 6.95 8.8 5 IHD Rapid
Mean ± SEM 48 ± 3 33 ± 3 6.56 ± 0.1 7.28 ± 1 35 ± 13
AUD, mild 25 43.5 6.7 6.9 552 CO and EtOH Intermediate
AUD, moderate 42 41 6.5 8 1472 Bromoxynil/EtOH Intermediate
AUD, remission 44 15 6.48 7.9 639 IHD Rapid
AUD, severe 45 18.5 6.57 7.9 1799 Drowning Intermediate
AUD, severe 49 44 6.41 6.4 1012 IHD Rapid
AUD, severe 49 16 6.19 6.2 613 MI Rapid
AUD, moderate 50 17 6.3 7.0 2453 IHD Rapid
AUD, severe 50 34.5 6.93 7.3 5212 Acute bronchitis Intermediate
AUD, severe 61 59 6.57 6.1 8052 Myocarditis Intermediate
AUD, severe 61 23.5 6.92 8.3 5621 IHD Rapid
Mean ± SEM 48 ± 3 31 ± 5 6.63 ± 0.1 7.2 ± 1 2743 ± 829
Detailed clinical data was collected for each subject as described in the “Methods” section. All subjects were male. AUD alcohol use disorder, PMI postmortem
interval, IHD ischemic heart disease, MI myocardial infarction, CO carbon monoxide. Agonal state terminal phase durations—rapid: <1 h, intermediate: 1–24 h,
long term >24 h
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Statistical analyses
Data are expressed as a mean values ± standard error
of mean from the indicated number of slices or ex-
periments. Student’s t tests were performed for two-
group analyses. For concentration-response curves, a
one-way ANOVA followed by Dunnett’s multiple
comparisons test was utilized. Differences were con-
sidered to be statistically significant if p value of
<0.05. For human brain tissue analyses, paired t tests
were performed between alcoholic subjects and their
matched controls. Pearson’s correlation test was
performed to assess for correlations of normally dis-
tributed data.
Results
Postmortem human alcoholic brains have increased TLR7,
HMGB1, and microglial activation
Previous studies have found alcoholic hippocampal neu-
rodegeneration [17], increased microglial markers and
cytokine expression [39], and TLR7 induced neuroim-
mune activation and neurodegeneration [6]. TLR7 acti-
vation leads to neuroimmune activation as well as
Fig. 1 Postmortem human alcoholic hippocampus shows increased TLR7, HMGB1, and CD11b expression. Frozen hippocampal tissue from
human alcoholics was obtained from the New South Wales Brain Tissue Bank. Either mRNA or protein was isolated. a TLR7 mRNA was 1.66-fold
greater in alcoholics. b TLR7 mRNA correlated positively with total drinking years across all subjects (R = 0.76, ***p < 0.005). c TLR7 protein was
measured by western blot. TLR7 was increased in the hippocampus of alcoholics by 31%. d TLR7 protein was also related to lifetime alcohol
consumption assessed by total drinking years. Pearson’s coefficient R = 0.43, p = 0.06. e HMGB1 protein was increased in the hippocampus of
alcoholics by 24% (195.5 ± 20.04 vs 157.8 ± 8.22 ng/mg total protein, alcoholics vs control, mean ± SEM). f CD11b protein expression was
increased by 40% in alcoholics showing microglia activation. Con-healthy controls, Alc-alcoholics (ALC). *p < 0.05, paired t test, N = 8–10 subjects
per group
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neurodegeneration [6]. However, a role for TLR7 in alco-
holism has not been described. To assess the involve-
ment of TLR7 and microglia in the pathology of
alcoholism, we obtained frozen hippocampal tissue of
postmortem human alcoholics from the New South
Wales (NSW) Brain Tissue Bank. Demographics and al-
cohol use history of alcoholics and healthy control sub-
jects are shown in Table 2. We found no significant
differences between groups in age (p = 0.98), PMI (p =
0.73), brain pH (p = 0.53), or RIN values (p = 0.9). RIN
values averaged 7.28 and 7.2 in control and alcoholic
groups, respectively, demonstrating similar and adequate
mRNA integrities for RT-PCR. Further, amplification oc-
curred prior to 40 cycles and single peak MELT curves
were seen consistent with detection of the target mRNA
of interest. Hippocampal tissue from alcoholics showed
increased expression of TLR7 mRNA (166%, p < 0.05)
than control moderate drinkers (Fig. 1a). TLR7 mRNA
correlated positively with lifetime alcohol consumption
as assessed by total drinking years (Fig. 1b, R = 0.76, p <
0.005) and kg alcohol/lifetime (R = 0.76, p < 0.005, not
shown) across all subjects. TLR7 protein was also in-
creased in postmortem hippocampal tissue from human
alcoholics (Fig. 1c). TLR7 protein showed a trend toward
a positive correlation with total drinking years (Fig. 1d)
that approached significance (Pearsons coefficient R =
0.43, p = 0.06). Neuroimmune responses to TLR7 in vitro
require HMGB1 [25]. In the hippocampus of alcoholics,
HMGB1 protein was increased by 24% as measured by
ELISA (Fig. 1e). To assess microglia, CD11b was mea-
sured by western blot. CD11b was increased in alco-
holics by 40, consistent with microglial activation
(Fig. 1f ). Thus, the neuropathology of human alcoholism
involves increased expression of TLR7, HMGB1, and
microglial CD11b.
Ethanol increases TLR7 expression and its ligand let-7b
and causes neuroimmune gene induction in rat HEC slice
culture
In order to investigate the role of ethanol induction of
TLR7 on signaling, we utilized the hippocampal-
entorhinal (HEC) slice culture. The miR let-7 is an en-
dogenous ligand for TLR7 that results in neurodegenera-
tion [6] and let-7 isoforms are increased in the brains of
human alcoholics [9]. Thus, we hypothesized that etha-
nol would increase TLR7 and let-7 expression in vitro
contributing to neuroimmune activation. The let-7b iso-
form in particular activates TLR7. Ethanol increased let-
Fig. 2 Ethanol increases miR let-7b, HMGB1 in hippocampal-entorhinal slice culture (HEC). HEC slices were exposed to ethanol for 48 h. Tissue
was collected for miRNA, mRNA, protein, or immunohistochemistry. Levels of miR let-7b, IL-1β, and TNFα mRNA were measured in brain slice
tissue using RT-PCR. TLR7 immunoreactivity (TLR7 + IR) was performed and mean pixel density measured. a TLR7 mRNA expression was increased
by ethanol in a dose dependent fashion, up to twofold control levels. b A 23% increase in TLR7 + IR (protein) was found (105.5 ± 1.9 vs 85.3 ± 6.7
mean pixel density ± SEM, Ethanol vs Control, **p = 0.01, t test, N = 5–6 per group). c HEC was exposed to ethanol (25–100 mM) for 48 h. Ethanol
increased HMGB1 protein (by ELISA) in the slice tissue by up to 85% in a concentration-dependent fashion. (One-way ANOVA F(4,5) = 48.07,
p < 0.0005, Dunnett’s multiple comparisons post-test *p < 0.02,***p < 0.001). d miR let-7 was increased 2.4-fold at 48 h of ethanol exposure (237 ± 16.0%
vs 100 ± 2.4%, Ethanol vs Control, mean ± SEM, **p < 0.01, t test
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7b expression in HEC slice tissue by more than twofold
at 48 h of exposure (Fig. 2a). Other let-7 family members
in addition to other pro-inflammatory miRNAs were
assessed and are shown in Additional file 4: Table S1.
This was associated with an increase in TLR7 mRNA
and protein (Fig. 2b, c). Similar to postmortem human
tissue, ethanol increased HMGB1 protein levels in HEC
slice culture in a concentration dependent fashion
(Fig. 2d). Significant increases in HMGB1 were seen at
50 mM ethanol (33%, **p < 0.01), with a trend toward an
increase at 25 mM (p = 0.056). Thus, ethanol treatment
of HEC brain slice cultures increases expression of
TLR7, let-7b, and HMGB1.
We next investigated the role of TLR7 in ethanol-
induced innate immune gene induction. TLR signaling
involves MyD88 coupling to other signaling proteins
leading to NFκB transcription of proinflammatory cyto-
kines [7]. Indeed, we found that ethanol increased phos-
phorylation of the p65 NFκB (pNFκB-p65) by nearly 2.2-
fold (Fig. 3a, 223.8 ± 22.15% vs 100 ± 9.2%, ethanol vs
control, ***p < 0.0003 t test). NFκB-associated innate im-
mune gene induction by ethanol was further evidenced
by increased levels of MyD88, a key TLR signaling pro-
tein (187% increase, Fig. 3b) and TNFα mRNA (249% in-
crease, Fig. 3c), and IL-1β (954% increase, not shown).
The TLR7 agonist imiquimod also caused increases in
TNFα and IL-1β (Additional file 2: Figure S2). We used
an siRNA against TLR7 (siTLR7) to assess the effect of
TLR7 signaling after ethanol. TLR7 siRNA effectively re-
duced TLR7 mRNA levels by 50% (100% ± 12.25 vs 49.6
± 3.16, p < 0.0001; mean ± SEM; siControl vs siTLR7).
MyD88 and TNFα gene expression caused by ethanol
were reduced by 81 and 69% respectively (Fig. 3b, c).
TLR7 can also activate IRF7 leading to interferon (IFN)
induction. We observed a slight increase in IFNα mRNA
(29% above control, p < 0.05, not shown) and a decrease
IFNγ mRNA (52% reduction, p < 0.05, not shown) in re-
sponse to ethanol. Thus, ethanol concomitantly induces
activation of both TLR7 and its endogenous ligand, let-
7b. Ethanol causes NFκB activation with associated in-
duction of MyD88, a key TLR adapter protein, as well as
proinflammatory cytokines associated with TLR7
activation.
Ethanol releases miR let-7b and HMGB1 complexes in
MVs from microglia
let-7b can be released from cells in extracellular micro-
vesicles (MVs) to exert its effects on recipient cells [40,
41]. HMGB1 is also released in vesicle response to in-
flammation or cellular stress [29, 42]. Therefore, we
assessed whether let-7b and HMGB1 were released in
MVs in response to ethanol, as this could serve as an
inter-cellular communication signal. We isolated vesicles
based on their size (0.1–1 μm). This population is
heterogeneous and may include both membrane-derived
microparticles and larger exosomes. Ethanol caused a
nearly fourfold increase in release of let-7b in media
Fig. 3 Induction of NFκB target genes by ethanol involves TLR7.
HEC slices were exposed to ethanol for 48 h. mRNA was isolated
from the tissue as described in the “Methods” section. Additional
groups were incubated with siRNA against TLR7 (siTLR7) to assess
for involvement of TLR7 role in induction of NFκB genes. a Ethanol
caused phosphorylation of the NFκB-p65, evidenced by a 2.2-fold
increase in pNFκB (p65) relative to controls (***p < 0.0003, t test).
Insert shows representative western blot samples of pNFκB-p65 and
β-actin. b MyD88 mRNA was increased by ethanol by 87% of control.
siRNA against TLR7 returned MyD88 to near control levels. c TNFα
mRNA was induced by ethanol by 246% at 48 h of ethanol exposure;
246.4 ± 10.243% vs 100.7 ± 11.8%, Ethanol vs Control, mean ± SEM.
siRNA against TLR7 significantly reduced TNFα mRNA levels to 146% of
control. Error bars denote mean ± SEM, ***p < 0.001 vs control, ###p<
0.001 vs ethanol. N = 2–10 slices per group
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MVs (Fig. 4a). We then asked which cell type was re-
sponsible for microvesicular let-7 and HMGB1 release.
We utilized specific cell lines to determine whether neu-
rons or microglia release let-7b in MVs. Ethanol caused
a threefold increase in MV let-7b from BV2 microglia
(Fig. 4b) but not SH-SY5Y neurons (Fig. 4c), suggesting
microglia are the source of secreted let-7. Ethanol also
caused a dose-dependent increase in media HMGB1
(Fig. 4d). Thus, ethanol releases let-7b and HMGB1
from HEC brain slice cultures and BV2 microglia.
Consistent with previous findings, ethanol stimulated
the release of HMGB1 in the absence of detectable cell
death as assessed by propidium iodine uptake (Fig. 7b,
c), consistent with active release from cells, rather than
passive release from necrotic cells [22]. Therefore, we
assessed ethanol-treated HEC slice media MVs to deter-
mine which cell types were secreting HMGB1. Using
flow cytometry of HEC media, we were able to identify
the cellular origin of HMGB1+ MVs. Media MVs were
labeled with fluorescent antibodies to HMGB1, GFAP
(astrocytes), CD11b (microglia), and Na+/K+ ATPase α3
(neurons). Flow cytometric analysis revealed that 73% of
the HMGB1-positive MVs were CD11b positive,
indicating microglial origin. Approximately 15.3 and
11.8% were positive for GFAP and Na+/K+ ATPase α3
indicating astroglial and neuronal origins, respectively
(Fig. 4e, f ). Thus, ethanol causes secretion of HMGB1 in
MVs primarily from microglia, as well as increasing let7b
secretion in MVs.
In addition to its DAMP actions as a TLR4 agonist,
HMGB1 also acts as a chaperone for nucleic acids, ster-
oid hormones [28], or cytokines [26] facilitating their
binding to their own receptors. Given the “chaperone-
like” nature of HMGB1 for nucleic acids, and our find-
ing of let-7b and HMGB1 in MVs derived from micro-
glia, we hypothesized that HMGB1 binds miR let-7b in
MVs. Micro-RNAs normally bind argonaute 2 (Ago2)
during the formation of the mature RNA-induced silen-
cing complex (RISC) [43]. However, miRNAs targeted
for secretion in MVs, rather than for intracellular
regulation of mRNA stability might involve different
chaperone proteins. In the case of let-7b, less than 20%
of let-7b is bound to Ago2 in MVs from human plasma
[44]. Therefore, we assessed let-7b binding to Ago2 and
HMGB1 in MVs. Using an RNA immunopurification
(RIP) assay, HMGB1 was immunoprecipated from HEC
Fig. 4 Ethanol causes microvesicle (MV) release of let-7b and HMGB1 from microglia. a MVs were isolated from hippocampal-entorrhinal slice
culture (HEC) media after ethanol exposure. let-7b was increased in MVs 3.7-fold by ethanol. b Ethanol increased let-7b in BV2 microglia-derived
MVs by 3-fold; 326.7 ± 76.3% vs 100 ± 18.2%, Ethanol vs Control, mean ± SEM, *p < 0.05, t-test. c SH-SY5Y neurons were treated with 100 mM
ethanol for 24 h. Ethanol had no effect on let-7b release in MVs from SH-SY5Y neurons; 95.75 ± 5.2% vs 100 ± 8.1%, Control vs Ethanol, mean ±
SEM. d Ethanol increased HMGB1 secretion into HEC culture media in a dose dependent fashion. e 72.9% of HMGB1+ MVs from HEC media are
microglial-derived, whereas astrocytes and neurons comprised 15.3 and 11.8%, respectively. One-way ANOVA with Sidak’s multiple comparisons
test, ****p < 0.00001. f Representative histogram of one ethanol treated sample showing populations of astrocytic (GFAP, dark gray), microglial
(CD11b, light blue), and neuron-derived HMGB1+ MVs (Na/K ATPase α3, light gray). *p < 0.05, **p < 0.01, mean ± SEM, N = 3–6 per group
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media MV followed by RT-PCR for miR let-7b. Ethanol
was found to increase the association of let-7b with
HMGB1 in MVs by 50% (Fig. 5a). Concomitantly, etha-
nol reduced the association of let-7b with its classical
chaperone protein argonaute (Ago2) [37] in microvesi-
cles by approximately 50% (Fig. 5b). In order to deter-
mine if this ethanol effect showed specificity for let-7b,
we assessed two additional relevant pro-inflammatory
miRNAs, miR-155 and miR181c. The miR-155 has been
shown previously to be increased by 2.5-fold in plasma
MVs in response to ethanol [24]. HMGB1 binding to
miR181c was non-detectable after ethanol treatment
(not shown). We found that ethanol increases miR-155
levels by 6.7-fold in our MV preparations (100 nm–
1 μm) from BV2 microglia (Fig. 5c). Ethanol did not,
however, increase the binding of HMGB1 with miR-155
(not shown), though miR-155 binding to Ago2 binding
was increased as expected (Fig. 5f). Thus, ethanol is alter-
ing miRNA-chaperone binding in MVs. Ethanol-induced
increases in let-7b binding to HMGB1 appear to be
unique from other ethanol-induced miRNAs. This could
be associated with the targeting of miRNA to MVs for se-
cretion rather than to the RISC complex for regulation of
mRNA stability and should be investigated in future stud-
ies. Regardless, ethanol increased HMGB1-let-7b com-
plexes in MVs released from HEC brain slices.
Ethanol enhances TLR7 mediated neurodegeneration, a
requirement of HMGB1
Since ethanol increases TLR7 expression, let-7 release,
and HMGB1 release, we hypothesized that the ethanol-
induced increase in TLR7 expression primes TLR7 sig-
naling and increases vulnerability to neurotoxicity due to
TLR7 activation. To model this, while preventing other
potential confounding effects of ethanol treatment, we
used a low dose of the TLR7 agonist imiquimod (IMQ)
to specifically prime TLR7 signaling, then assessed the
effects of ethanol. Indeed, a low dose of IMQ resulted in
a moderate increase in neurodegeneration, with ethanol
addition after TLR7 priming causing nearly a fourfold
increase in neurodegeneration (Fig. 6a). Next, we investi-
gated the effect of ethanol on the endogenous TLR7
agonist, let-7b. First, we confirmed that let-7b causes
neurodegeneration through TLR7 in our culture using
siRNA to TLR7 and a let-7b mimic (Fig. 6b). We then
found that ethanol does indeed potentiate let-7b-
induced neurotoxicity (Fig. 6c). Ethanol also potenti-
ated neuroimmune responses to a low dose of non-
neurotoxic let-7b mimic (100 nM), increasing IL-1β
expression by fourfold greater than let-7b alone (not
shown). Thus, sensitization of TLR7 signaling with ei-
ther IMQ or let-7 results in increased neurotoxicity
to ethanol.
Fig. 5 Ethanol alterations in miRNA expression and chaperone protein binding in microvesicles (MVs). Hippocampal-entorhinal (HEC) slices were
treated with ethanol (100 mM) and RNA immunopurification (RIP) assay was utilized to assess let-7b complex formation with chaperone proteins.
a RIP assay found that ethanol increases the association of let-7b with HMGB1 in MVs by 50%. b Ethanol reduces let-7b binding to argonaut
(Ago2) by 50%. c Ethanol caused a robust increase in miR-155 in BV2 microglial MVs. d miR-155 binding to Ago2 was increased in HEC media
MVs after ethanol treatment. Mean ± SEM, *p < 0.05, N = 3–6 per group
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Our finding of increased HMGB1 binding to let-7b in
MVs after ethanol, coupled with previous observations
of HMGB1 involvement in TLR7 agonist activation [25],
suggested that HMGB1 may be acting as a chaperone,
facilitating let-7b secretion in MV and binding to TLR7.
In the HEC slice culture model, ethanol treatment alone
causes neurotoxicity during withdrawal, i.e., following
ethanol removal and involves glutamate excitotoxicity
[45–49]. However, we have shown previously that glu-
tamate toxicity requires HMGB1 release [50]. Thus, we
hypothesized that HMGB1 release would be involved in
ethanol withdrawal-induced neurotoxicity. Indeed, we
observed that HMGB1 is required for ethanol-induced
neurotoxicity (Fig. 7a). The HMGB1 antagonist glycyr-
rhizin (GLY) blocks both HMGB1 binding and release
[51, 52]. GLY protected against ethanol-induced neuro-
toxicity during withdrawal. Further, let-7b was increased
in MVs by 28% during ethanol withdrawal (not shown).
HMGB1 has been shown to be required for TLR7-
dependent immune responses in vitro [25]. Thus, we
also investigated if HMGB1 is required for TLR7-
induced neurodegeneration. We found that HMGB1 in-
hibition with GLY reduced neurodegeneration caused by
the TLR7 agonist IMQ, with protecting against TLR7
mediated cell death (Fig. 7b). Thus, HMGB1 release is
critical role in for neurotoxicity due to both ethanol and
TLR7 activation. Neurodegeneration in human alcohol-
ism involves cycles of chronic binge ethanol exposures
and withdrawals. Our findings indicate that alcohol
causes microglia to release let-7 and HMGB1 in MVs
while concomitantly increasing TLR7 expression, leading
to neurodegeneration. Thus, ethanol increases TLR7-
induced neurodegeneration, through induction of TLR7,
let-7 release, and HMGB1 secretion.
Discussion
The identification of endogenous ligands for TLRs has
transformed the concept of inter-cellular signaling and
innate immune activation. Let-7 release in MVs in par-
ticular has also been implicated in multiple inflamma-
tory pathologies related to cancer, cardiovascular disease,
and neurodegeneration [6, 53, 54]. We report here that
ethanol exposure increases TLR7 expression and release
of let-7b in microglia-derived microvesicles to promote
neurodegeneration (Fig. 8). TLR7 mRNA and protein, as
well as the microglial activation marker CD11b were
Fig. 6 Ethanol enhances TLR7-mediated neurotoxicity. Hippocampal-entorhinal (HEC) slices were treated with TLR7 agonist Imiquimod (IMQ,
500 ng/mL), let-7b (5 μM), or ethanol (100 mM) for 48 h. Cell death was assessed by fluorescent propridium iodide (PI) uptake. a Brain slice
cultures were treated with a low dose of IMQ (500 ng/mL) or vehicle for 48 h, followed by addition of either ethanol (100 mM) or vehicle for
4 days to assess whether TLR7 pre-sensitization with IMQ would result in ethanol induced neurotoxicity. IMQ treatment caused a 75% increase in
PI staining over control. Ethanol robustly increased neurotoxicity (284% greater than control and 119% greater than IMQ alone) *p < 0.05 vs
control, #p < 0.05 vs IMQ alone, N = 7–14 slices per group. b let-7b caused neurotoxicity in HEC slice tissue as shown by a greater than twofold
increase in PI uptake relative to control. siRNA against TLR7 mRNA (siTLR7) prevented let-7 induced neurotoxicity. *p < 0.05 vs control, #p < 0.05 vs
let-7b alone, N = 7–14 slices per group. c Ethanol potentiated let-7b-induced neurotoxicity (37.05 ± 2.4 vs 23.1 ± 1.7 mean fluorescent intensity)
****p < 0.0001 vs siControl, ####p < 0.0001 vs let7b, t test, N = 10 slices. d Representative images of PI staining in hippocampal region of HEC
slices. Arrows show neurotoxicity in dentate gyrus and CA1. Ethanol enhanced IMQ-TLR7 and let-7b induced neurotoxicity
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increased in postmortem hippocampal tissue of alcoholics
consistent with our in vitro findings. TLR7 mRNA
changes were greater than that of TLR7 protein. This may
be due to many factors such as translational repression
[55]. The correlation of TLR7 expression with lifetime
consumption of alcohol suggests a role of TLR7 signaling
in the pathology of alcoholism. Ethanol also increased the
binding of let-7b to the DAMP and chaperone HMGB1,
while reducing let-7b binding to Ago2. This shifting of the
chaperone protein association of let-7b might alter its
function or initiate targeting to microvesicles. Traditional
dogma is that miRNAs bind with Ago2 during the forma-
tion of the RISC complex and subsequent regulation of
mRNA stability [43]. The export of miRNAs in MVs as
potential TLR7 agonists is a new and emerging concept.
Little is known about the targeting of miRNAs to vesicles
for release versus to the cytosol for mRNA regulation. Fu-
ture studies are warranted to better understand how dif-
ferent miRNA chaperone proteins, such as HMGB1
versus Ago2, differentially effect miRNA destination and
function. HMGB1 is known to be secreted in microvesi-
cles [42, 56] and might escort let-7 to microvesicles for se-
cretion, rather than to the Ago2-associated RISC complex,
where it would subsequently act intracellularly to regulate
the stability target mRNAs. We also found that HMGB1
inhibition prevented TLR7-mediated neurotoxicity. This is
consistent with a previous report showing that HMGB1 is
required for TLR7-mediated immune responses in mouse
embryonic fibroblasts [25]. Simultaneous activation of
TLR4 and TLR7 with LPS and loxorobine respectively did
not result in increased toxicity in mixed neuronal-
microglia cultures [57]. Therefore, we think the require-
ment for HMGB1 involves facilitating the interaction of
let-7 with TLR7, rather than a requirement for co-
stimulation of TLR4 by HMGB1. The importance of
miRNA signaling has been identified in several aspects of
alcohol use disorders. During fetal alcohol exposure, etha-
nol disrupts miRNA profiles to modulate neurodegenera-
tion and proliferation [58, 59]. In adults, ethanol causes
systemic release of miR-155 and miR-27a to regulate
TLR4 signaling and monocyte activation state, respectively
[60, 61]. Many miRNAs, including let-7 isoforms, are up-
regulated in the brains of humans and mice after chronic
alcohol [8, 9]. We identify a role of let-7 in the pathology
of alcoholism that involves inter-cellular signaling through
TLR7, rather than its intracellular function involving
mRNA stabilization.
We also found that HMGB1 was required for ethanol
withdrawal-induced neurotoxicity. Studying withdrawal
in the HEC slice culture model is critical, since ethanol
exposure itself does not cause cell death. Consistent with
previous studies using hippocampal slice culture,
ethanol-induced neurotoxicity was seen during the etha-
nol withdrawal phase [45–49]. This withdrawal toxicity
is known to involve glutamate release [47]. However, we
found that inhibition of HMGB1 prevented ethanol
withdrawal neurotoxicity. We have found previously that
glutamate toxicity in the absence of ethanol also involves
HMGB1 release, with glycyrrhizin preventing death [50].
Fig. 7 Ethanol and TLR7-induced neurodegeneration require HMGB1
release. a Hippocampal brain slice cultures were treated with
ethanol or vehicle alone for 48 h followed by 24 h of ethanol
withdrawal (WD) to induce neurotoxicity +/− HMGB1 antagonist
glycyrrhizin (GLY, 100 μM). Ethanol resulted in neurotoxicity during
withdrawal as assessed by propridium iodide uptake (35.5 ± 2.32
vs17.08 ± 2.5, mean ± SEM) ****p < 0.0001 vs control. GLY prevented
neurotoxicity during withdrawal. ##p < 0.01. b Hippocampal brain
slice cultures were treated with the TLR7 agonist imiquimod (IMQ,
10 μg/mL) or vehicle for 48 h +/− GLY (100 μM). Neurotoxicity was
assessed by PI uptake. IMQ treatment caused neurodegeneration
with a 67.6% increase in PI uptake. This was diminished greatly by
GLY (97.4% reduction). **p < 0.01 vs control, #p < 0.05 vs IMQ alone.
N = 7–10 slices per group
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The exact role of HMGB1 in withdrawal toxicity is not
clear. However, TLR4 responses have been shown to be
inhibited during the neurotoxic withdrawal phase in
HEC cultures [49]. We found, however, that TLR7 re-
sponses during ethanol withdrawal are enhanced and re-
quire HMGB1 (Additional file 3: Figure S3). This also
suggests that the requirement for HMGB1 during etha-
nol withdrawal might not involve its actions at TLR4,
but might rather involve TLR7. We also found that let-
7b is released during withdrawal. Future studies should
investigate the role of HMGB1, let-7, and TLR7 in etha-
nol withdrawal-induced toxicity. Human alcoholism in-
volves frequent exposures of chronic alcohol followed by
withdrawal. Our findings suggest that recurrent TLR7
activation by ethanol-induced microglial let-7 and
HMGB1 release contributes to the progressive neurode-
generation associated with alcoholism. This sensitization
of microglia to release pro-inflammatory MVs may be
similar in Parkinson’s, Alzheimer’s, and other neurode-
generative diseases.
It is important to note that high ethanol concentrations
(>75 mM) were used in HEC slice culture and in vitro cell
line experiments. However, human alcoholics reach very
high blood alcohol concentrations (BACs). A report of
117 alcoholics showed that >57% had BACs from 43 to
125 mM [62], with alcoholics remaining functional at
higher BACs [63]. Further, the in vitro findings of in-
creased HMGB1 and TLR7 are seen in postmortem hu-
man alcoholics and are of similar magnitude. Thus, the
concentrations used in our in vitro studies appropriately
model the human condition. Also, it is important to note
that different cell lines might have different features. We
employed in vitro models from a variety of sources includ-
ing rat hippocampal slice culture, mouse BV2 microglia,
and human SY-SY5Y neurons. The rat hippocampal slice
culture has all brain cell types present in their native con-
figurations making it the best in vitro system we have
employed. The combination of these tools shows that
microglia are the primary source of let-7b in MVs in re-
sponse to ethanol. Though the use of multiple systems
strengthens our conclusions, other neuronal or microglial
cell lines might show different responses and should be in-
vestigated in future studies.
Our findings elucidate a novel mechanism of inter-
cellular communication in neuroimmune pathology
(Fig. 8). Flow cytometric and cell line studies identified
microglia as the primary source of the MV-secreted
HMGB1 and let-7b. These findings are consistent with our
previous in vivo findings of activated microglia following
ethanol [19, 64, 65], evidence of microglial sensitization in
postmortem human alcoholic brain [39], and the in vitro
observation that the microglia are required for neuronal
death due to agonists to TLR2, 4, and 9 [57]. Our findings
further emphasize the need to develop microglia-targeted
therapies for neuroimmune diseases. Also, the observation
that ethanol increases the formation of HMGB1-let-7b
complexes, and that HMGB1 inhibition prevents TLR7 in-
duced neurotoxicity, uncovers a new potential for HMGB1
inhibition in preventing alcohol-induced and other neu-
roimmune pathologies. The investigation of the mecha-
nisms of MV packaging of contents and secretion might
also produce additional therapeutic targets. Further,
Fig. 8 Proposed mechanism of HMGB1 and let-7 release in microvesicles. Ethanol causes an increase in TLR7 expression, and release of let-7b
and HMGB1 from microglia in microvesicles, potentiating neurodegeneration. Ethanol increases the binding of let-7 with HMGB1 in microvesicles.
HMGB1 inhibition with glycyrrhizin prevented TLR7 mediated neurotoxicity
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several let-7 family members and other miRNAs were al-
tered by ethanol in MVs (Additional file 4: Table S1), war-
ranting further future investigation. The method of MV
isolation used in this study yields vesicles between 0.1 and
1.0 μm in diameter. The origin of these particles may in-
clude exocytosis of multivesicular bodies, budding of the
plasma membrane, or autophagy-associated secretory vesi-
cles from living cells [66–68]. Identification of the mecha-
nisms underlying this MV secretion may produce novel
pharmacological targets for alcoholism or other conditions
involving neuroimmune activation. In summary, we iden-
tify a novel inter-cellular neuroimmune mechanism in-
volved in the pathology of alcoholism that provides
multiple potential therapeutic targets.
Conclusions
We find increased TLR7 in alcoholic hippocampus and
with ethanol treatment of slice cultures. Ethanol increases
TLR7 activation and releases of HMGB1-miR-let-7 com-
plexes in microglia-derived vesicles that cause neurotoxicity
via TLR7 activation. TLR7 activation by alcohol in humans
may contribute to the neuropathology of alcoholism.
Additional files
Additional file 1: Figure S1. Flow cytometric assessment of
microvesicles. Microvesicles (MVs) were isolated by size using centrifugation
(21,000g for 1 h) and analyzed by flow cytometry. (A) Depiction of size
gating for microvesicles (0.1 to 1.0 μm) using MegaMixTM gating beads. (B)
Specific staining for cell-type markers was determined by comparison with
unstained controls. Depictions of unstained (gray) and single color controls
for each primary antibody are shown. These were used for determination of
compensation matrix and identification of specific populations (arrows).
(TIF 49286 kb)
Additional file 2: Figure S2. TLR7 agonist imiquimod (IMQ) increases
TLR7, let-7b, and neuroimmune markers in brain slice tissue similar to
ethanol. (A) TLR7 mRNA expression was increased by 3.8-fold by IMQ
treatment (10 μg/mL, 48 h). (B) IMQ increased expression of IL-1β (peak
60-fold) and TNFα mRNA (peak 12-fold) after 24 and 48 h of exposure. (C)
Media HMGB1 was increased by IMQ (10 μg/mL) rapidly within 8 h
(threefold) and then reached a fourfold total increase at 48 h. (D) let-7b
miR was increased by twofold in brain slice culture after 24 h exposure to
IMQ (**p < 0.01). (E) Imiquimod increased let-7b release in microvesicles
from 24–48 h in a fashion similar to ethanol. let-7b levels were threefold
control at 24 h and fivefold control at 48 h. Error bars denote mean ± SEM.
*p < 0.05, **p < 0.01 (TIF 2159 kb)
Additional file 3: Figure S3. Ethanol withdrawal enhances TLR7
neurotoxicity by HMGB1 release. HEC slices were treated with ethanol
(100 mM), imiquimod (IMQ, 10 μg/mL) vehicle for 48 h. During the 24-h
withdrawal period, slices either had vehicle, IMQ, or IMQ + glycyrrhizin
(100 μM). Cell death was quantified using propridium-iodine uptake. (A)
IMQ treatment during withdrawal produced greater neurotoxicity than
either ethanol withdrawal or IMQ alone. HMGB1 inhibition was with GLY
prevented the ethanol induced enhancement. (B) Representative images
of each treatment condition. N = 7–10 slices. *p < 0.05 vs control. #p <
0.05 vs IMQ alone or WD + IMQ. (TIF 2299 kb)
Additional file 4: Table S1. Effect of ethanol on selected miRNAs in
hippocampal entorhinal cortex (HEC) slice culture microvesicles (MVs) and
tissue. HEC sections were treated with ethanol (100 mM) for 48 hours. MVs
and tissue were analyzed for miRNA expression by RT-PCR and expressed as
percent of control ± SEM. *p < 0.05, **p < 0.01, t test (DOCX 16 kb)
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